Chair Thomas Vorup-Jensen & Poul Sørensen
Chair Hans Jürgen Hoffmann & Poul Sørensen
Chair Martin K. Thomsen & Søren E. Degn
13:00 – 14:00 registration, networking
13:50 – 14:00 Welcome and house rules: Thomas Vorup-Jensen
Chairs: Poul Sørensen, Martin Thomsen
14:00 – 14:30 Paul Eggleton, Revolo Biotherapeutics, New Orleans, USA. Therapeutic chaperones IRL201104 & IRL201805: returning out of balance immune systems to a normal state in inflammatory diseases
14:30 – 15:00 Göran Forsberg, Cantargia, Lund, Sweden: Antibody targeting of IL1RAP for treatment of cancer and inflammatory disease
15:00 – 15:30 Christian L. Hvas, Aarhus University, Aarhus, Denmark: Faecal microbiota transplantation: restoring intestinal immunotolerance
15:30 – 16:30 networking & coffee
Chairs: Hans Jürgen Hoffmann, Søren Degn
16:30 – 17:00 Anton Lindquist, Diamyd Medical, Stockholm, Sweden: Can parenteral administration of the autoantigen GAD65 induce tolerance and preserve beta cell function in type 1 diabetes?
17:00 – 17:30 Margriet J Velvoordeldonk, Galvani Bioelectronics, Stevenage, UK: Targeted splenic neuromodulation – the new frontier in therapies for autoimmune diseases
17:30 – 18:00 Alexander Scheffold, Christian-Albrechts-Universität, Kiel, Germany: Antigen-specific regulation of tolerance versus immune pathology in humans
18:00 – 18:30 Julie Rask Larsen, ALK, Hørsholm, Denmark: Real-world long-term effectiveness of allergen immunotherapy
18:30 – 20:30 Networking dinnertoire
The meeting is sponsored by companies from the pharmaceutical industry and major purveyors of scientific equipment
Thursday 24. November 2022, 13:00-20:00
Aula, Aarhus University
13:30-15:30
Coffee and networking
16:15-18:00
Cocktail dinatoire
Thursday November 25th, 1:00-8:00 PM
Aulaen (Bldg. 1412), Ndr. Ringgade, Aarhus University
2:00-3:40 pm
-Networking & Coffee-
4:30-6:30 pm
-Networking and Cocktail dinatoire-
Thursday November 26th 2020, 3:00-6:30 PM CET
Webinar
3:00-4:00 pm CET
Solange Peters, Lausanne University, Lausanne, CH:
“Promises and limitations of immunotherapy for lung cancer”
Malte Peters, Morphosys AG, Munich, DE:
“Modern drug development using real world data approaches”
-BREAK-
4:15-5:45 pm CET
Mario Ehlers, Boehringer Ingelheim, Ridgefield, US:
“T cell exhaustion as a therapeutic strategy in autoimmunity”
Stinne Greisen, Aarhus University, Aarhus, DK: ”Co-inhibitory receptors in arthritic conditions - their relation to disease activity and tissue preservation”
Michael Ehrenstein, University College London, London, UK: ”Anti-TNF was the first regulatory T cell targeted therapy for rheumatoid arthritis”
-BREAK-
6:00-7:00 pm CET
Adam Sander, AdaptVac, Copenhagen, DK: “Development of a COVID-19 vaccine based on virus-like particles displaying the SARS-CoV-2 receptor-binding domain”
Stephen Durham, Imperial College, London, UK: “New indications for allergen immunotherapy”
Thursday November 28th, 2019 13:00-20:00
Lake Side Lecture Theatres, Aarhus University, Aarhus, Denmark
All talks 20 min + 10 min discussion
13:00 - 14:00 registration & networking
Session 1
Chairs: Thomas Vorup-Jensen & Poul Sørensen
Simon Davis, University of Oxford, UK (Keynote)
14:00 - 14:40 Leveraging immune receptor signalling - new routes to therapeutic intervention
Søren Paludan, Aarhus University, DK
14:40 - 15:10 Modulation of lupus disease by targeting the STING pathway
Philippe Moingeon, Servier, Suresnes, FR
15:10 - 15:40 Molecular stratification of patients with autoimmune diseases: applications to new treatment development
15:45 - 16:45 Coffee
Session 2
Chairs: Hans Jürgen Hoffmann & Philippe Moingeon
Eric Vivier, Innate Pharma, Marseille, FR
16:45 – 17:15 Targeting innate immunity in cancer
Allan Jensen, Lundbeck, Valby, DK
17:15 - 17:45 Active immunization for treatment or prevention of neurodegenerative diseases
Georg du Toit, Kings College, London, UK
17:45-18:15 Recent advances in the prevention of food allergy
Networking and cocktail dinatoire 18:30 – 20:00
Sign-up participants and sponsors: events.au.dk/AIS5
Aarhus University: Thursday November 29th, 2018 13:00-22:00
All talks 20 min + 10 min discussion
13:30 - 14:00 registration & networking
Welcome: Dean, Faculty of Health, Aarhus University
Chairs: Thomas Vorup-Jensen & Georg Holländer
Bernard Malissen, CIML, Marseille, FR (Keynote)
14:00 - 14:40 In the LEGO box of the TCR system ... from the list of parts to the assembly instructions!
Rikard Holmdahl, Karolinska Institutet, Stockholm, SE
14:40-15:10 How autoreactive lymphocytes learn about tissue specific antigens in cartilage
Søren Degn, Aarhus University, DK
15:10 - 15:40 Beyond antibodies – pleiotropic functions of B cells in autoimmune disease
Birgitte Ursø, LEO Pharma, Ballerup, DK
15:40 - 16:10 Translational drug discovery in biologics from early discovery to clinical testing
16:10 - 16:30 Pause 20 min, coffee
Chairs: Hans-Jürgen Hoffmann & Poul Sørensen
Georg Holländer, Univ. of Oxford, UK
16:30 – 17:00 Deconstructing the thymus: Molecular insight into thymus development and function
Eva Pålsson-McDermott, Trinity College, Dublin, IRL
17:00 - 17:30 The role of metabolic reprogramming in macrophage effector function
Peter S. Andersen, ALK, Hørsholm, DK
17:30-18:00 Antibody repertoire development during sublingual allergy immunotherapy
Mo Shamji, Imperial College, London, UK
18:00-18:30 Peptide allergen immunotherapy: Ready for prime time
Networking and cocktail dinatoire 18:30 – 20:00
Aarhus University: Thursday November 30st, 2017 13:00-18:00
All talks 20 min + 10 min discussion
13:30 - 14:00 registration & networking
Welcome: Ole Steen Nielsen, Vice-Dean, Faculty of Health, Aarhus University
Chairs: Thomas Vorup-Jensen & Poul Sørensen
John Haurum, F-star, Cambridge, UK (Keynote)
14:00 - 14:40 Immuno-oncology: Revolutionizing cancer care
José Moreira, Copenhagen University, Denmark
14:40-15:10 Biomarkers for patient risk stratification: a rational approach to cancer prevention
Martin R. Jakobsen, Aarhus University, Denmark
15:10 - 15:40 Triggering the innate immune system: a novel approach to tumour remission
Per thor Straten, University Hospital Herlev, Denmark
15:40 - 16:10 Therapy of solid cancers using T cells and running shoes
16:10 - 16:30 Pause 20 min, coffee
Ivan Horak, Symphogen, Lyngby, Denmark
16:30 – 17:00 Precision medicine in the era of targeted therapy; from clinic back to bench
Ida Hiemstra, Genmab, Utrecht, Holland
17:00 - 17:30 Translating basic science to antibody therapeutics
Bent Jakobsen, Immunocore, Oxford, UK
17:30-18:00 Fine-tuned T cell receptors for cancer immunotherapy
Networking and dinner 18:00 – 22:00
Thursday 3 December 2015 14:00 - 19:00
Merete Barker Aud., The Lakeside Lecture Theatres, Bartholins Allé 3, 8000 Aarhus C
14:00 - 14:30 Registration & networking
All talks 20 min + 5 min discussion
Session 1: AIT State-of-the-Art
Chairs: Hans Jürgen Hoffmann, Aarhus University & Hospital; Poul Sørensen, Stallergenes Greer & Aarhus University; Steffen Thiel, Aarhus University
14:30 - 14:55 Allergen Immunotherapy Efficacy, safety and long term benefits. SCIT or SLIT?
Prof. Stephen R. Durham, Imperial College London, UK
14:55 - 15:20 Tolerance induction and prevention in allergy - a public health issue
Prof. Erkka Valovirta, University of Turku, Turku, Finland
15:20 - 15:45 Clinical Outcome Measures in AIT
Prof. Oliver Pfaar, Heidelberg University & Center for Rhinology and Allergology,
Wiesbaden, DE:
15:45 - 16:10 Biomarkers of SLIT efficacy: a "panorOmic" view
Dr. Philippe Moingeon, Stallergenes Greer, Paris, France
16:10 - 16:35 Basophil Sensitivity and ISAC as Biomarkers for SCIT
Dr. Johannes Schmid, Aarhus University, Denmark
16:35 - 17:00 Coffee break and networking
Session 2: Emerging new AIT approaches
Chairs: Hans-Jørgen Malling, Gentofte Hospital, Hellerup; Edzard Spillner, Immunological Engineering, Aarhus University
17:05 - 17:30 Targeting T cells with peptide immunotherapy
Prof. Mark Larché, McMaster University, Hamilton, Ontario, Canada
17:30 - 18:05 The good “COP”: AIT with <10% of the doses needed with extracts
Dr. Kim Simonsen, Chief Development Officer, Anergis SA, Switzerland
18:05 - 18:30 Introducing ILIT in Sweden
Prof. Lars Olaf Cardell, Lund University & Karolinska Institute, Sweden
18:30 - 19:00 A double-blind, placebo controlled trial to compare three and four injections in ILIT
Dr. Søren Helbo, Aarhus University, Aarhus, Denmark
19:15 Dinner and networking at ”Kemisk Kantine”, Langelandsgade 38, Bldg. 1510, 8000 Aarhus C
